09 December 07 - 06:02

Multiple Sclerosis-growing amount of data

2.5 Million+ people living with Multiple Sclerosis Worldwide.

Multiple Sclerosis - a painful, debilitating, and sometimes fatal disorder of the central nervous system. MS is the most common debilitating neurological disease of young people, often appearing between the ages of 20 and 40. Symptoms vary considerably from person to person; however, one frequently noted is spasticity, which causes pain, spasms, loss of function, and other problems.

Many MS patients report that cannabis has a startling and profound effect on muscle spasms, tremors, balance, bladder control, speech and eyesight.

Many wheelchair-bound patients report that they can walk unaided when they have smoked cannabis.

A House of Lords report states that the British Multiple Sclerosis Society (consisting of some 35,000 MS-suffering patients) estimates that as many as 4% of their population already use cannabis for the relief of their symptoms despite the considerable legal risks associated with prohibition.

The chairman of the committee went on to state that, "We have seen enough evidence to convince us that a doctor might legitimately want to prescribe cannabis to relieve...the symptoms of multiple sclerosis and that the criminal law ought not to stand in the way."

Cannabinoids have been shown in animal models to measurably lessen MS symptoms and may also HALT THE PROGRESSION of the disease.

A recent British survey of MS patients found that 43 percent of respondents used cannabis therapeutically. Among them, nearly three quarters said that cannabis mitigated their spasms, and more than half said it alleviated their pain. A survey published in August 2003 in the Canadian Journal of Neurological Sciences reported that 96 percent of Canadian MS patients believe that cannabis is therapeutically useful for treating the disease.

Of those who admitted using cannabis medicinally, the majority found it to be beneficial, particularly in the treatment of chronic pain, spasticity, and depression. The accompanying editorial states, "This is an exciting time for cannabinoid research. There is a growing amount of data to suggest that cannabis (marijuana) can alleviate symptoms like muscle spasticity and pain in patients with MS."

http://www.safeaccessnow.org/article.php?id=4558#research



No comments


No trackbacks:

You will need to enable javascript to generate a trackback link



Name:  
Remember personal info?
Yes
No
Email:
Comment: Emoticons Textile

   Please enter the security code shown
at left into the box below:

 
 

Notify:
Hide email:

Small print: All html tags except <b> and <i> will be removed from your comment. You can make links by just typing the url or mail-address.